OWEN N. WITTE

Insider Reports History

Location
South San Francisco, CA
Signature
/s/Earl Douglas, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by OWEN N. WITTE:

Company Role Class Num Shares Value Price $ Report Date Ownership
Allogene Therapeutics, Inc. Director Restricted Stock Unit 95,400 18 Jun 2025 Direct

Insider Reports Filed by OWEN N. WITTE

Symbol Company Period Transactions Value $ Form Type Role Filing Time
ALLO Allogene Therapeutics, Inc. 18 Jun 2025 1 $0 4 Director 23 Jun 2025, 21:03
ALLO Allogene Therapeutics, Inc. 05 Jun 2024 1 $0 4 Director 07 Jun 2024, 17:29
ALLO Allogene Therapeutics, Inc. 13 Jun 2023 1 $0 4 Director 15 Jun 2023, 17:00
ALLO Allogene Therapeutics, Inc. 11 Aug 2022 2 -$251,250 4 Director 15 Aug 2022, 17:40
ALLO Allogene Therapeutics, Inc. 11 Aug 2022 2 -$251,250 4 Director 15 Aug 2022, 17:12
ALLO Allogene Therapeutics, Inc. 22 Jun 2022 1 -$117,600 4 Director 23 Jun 2022, 16:40
ALLO Allogene Therapeutics, Inc. 15 Jun 2022 2 $0 4 Director 17 Jun 2022, 16:58
ALLO Allogene Therapeutics, Inc. 09 Sep 2021 1 -$127,700 4 Director 09 Sep 2021, 17:32
ALLO Allogene Therapeutics, Inc. 20 Aug 2021 2 -$234,700 4 Director 23 Aug 2021, 16:22
ALLO Allogene Therapeutics, Inc. 09 Jun 2021 2 -$249,723 4 Director 11 Jun 2021, 17:48